NORML

MARCH 18, 2019

It expands the pool of patients eligible for cannabis therapy to include those diagnosed with post-traumatic stress, severe chronic pain, Crohn’s disease, Lou Gehrig’s disease, sleep apnea, and neuropathy, among other newly specified conditions. Nonetheless, Gov.

Decriminalization

Cannabis Law Report

MARCH 3, 2020

In Indianapolis on January 29, a quiet, eager audience of nurses give their rapt attention to Jason Straw as he takes center stage at the 2020 ISNA Policy Conference. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. Effective Date: 2019.

Policy

MedicalJane

JUNE 12, 2020

The research findings of the study, entitled “A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health,” was published this week in the journal Cannabis and Cannabinoid Research , Volume X, Number X, 2020. Study Findings.

Chronic Pain

The Joint Blog

DECEMBER 3, 2020

Sleep is vital for the healthy functioning of the human body. As per the National Sleep Foundation , almost 70 million U.S. adults feel sleep disorder symptoms like insomnia during their lifetime. The lack of sleep can also lead to other serious health issues like anxiety, depression, and accidents. What is Cannabis?

Sleep

United Patients Group

NOVEMBER 6, 2023

Insomnia and sleep disorders : Medical cannabis, particularly strains with higher levels of CBD, has been found to improve sleep quality. A review in 2020 found that CBD might improve sleep by reducing anxiety. According to a 2018 review of research studies, cannabis was found to be effective in managing chronic pain.

Chronic Pain

CannaTech

AUGUST 9, 2020

In the first half of 2020, CBD companies are experiencing a loss in revenue due to store closures and consumer concerns about Coronavirus and their finances. billion in sales in 2020, with 14% growth over 2019 sales of $4.1 Pharmacy holds the second largest share with a 14% share in 2020, up from 10% in 2019. COVID-19 Impact.

Wellness and Beauty

The Cannigma

AUGUST 31, 2022

The biphasic effects of these cannabinoids means a low dose is necessary to get these mood boosting benefits, as they can have inverse effects at larger doses. Both cannabinoids can also reduce inflammation so consuming the plant post-workout can also help with delayed onset muscle soreness (DOMS) or stiffness.

Terpenes

Cannabis Law Report

FEBRUARY 23, 2020

The Observer— Complete CBD Oil Guide 2020. CBD Oil Guide 2020. CBD oil is said to be more concentrated and, therefore, reputedly works better than hemp oil when it comes to effectively treating anxiety disorders, arthritis and sleep deprivation. “The endogenous cannabinoids in the body are also found in the brain.

Oil

Project CBD

FEBRUARY 28, 2023

This was somewhat less than the nearly 37% decline seen in 2020. sativa do not naturally contain cannabinoids, but they can become contaminated with CBD from other plant parts during processing. decline from 2020. COVID-19 plus legal uncertainty slowed CBD sales in 2020. million on these products. 2 The seeds of C.

CBD

The Cannigma

JUNE 16, 2022

But when looking for strains for seniors, you’re better off to focus less on the strain name and more on the chemical profile of the cannabis – first evaluating which cannabinoids are present and then considering the terpenes. In other words – the cannabinoid preparation worked. Appetite stimulation. Boosting mood and energy.

Terpenes

The Cannigma

MARCH 18, 2021

41% said cannabis somewhat addressed motor symptoms (43% for stiffness and 42% for tremors) 43% said cannabis somewhat addressed non-motor symptoms (46% for anxiety, 44% for sleep disorders, 44% for pain). The study was compiled by way of an anonymous email survey sent to 7,607 people with Parkinson’s disease in January 2020.

Patients

Cannabis Law Report

JULY 8, 2021

Seeks To Identify Novel Cannabinoids For Therapeutic Use. Following the execution of this work, cbdMD Therapeutics will perform the requisite toxicological studies with Ion Tox, a leading in vitro toxicology and ADME-PK testing company, to support the safety of the cannabinoids of interest. CHARLOTTE, N.C.–(BUSINESS

Research and Development

CannaTech

AUGUST 9, 2020

In the first half of 2020, CBD companies are experiencing a loss in revenue due to store closures and consumer concerns about Coronavirus and their finances. billion in sales in 2020, with 14% growth over 2019 sales of $4.1 COVID-19 Impact. unemployment rate in June, up from 3.8% in February.

CBD

The Cannigma

JUNE 24, 2021

For instance when it comes to pain relief, THC and CBD have shown to be safer than opioids; and for anti-anxiety and sleep aids, CBD does not appear to be habit-forming like benzodiazepines. Getting a good night’s sleep is a crucial step in leading a healthier lifestyle, and the benefits can be felt throughout the day.

CBD

Veriheal

JANUARY 26, 2023

Thus, this groundbreaking study laid the foundation for understanding how cannabinoids can support mental health. A 2020 study from the University of New Mexico recently unveiled promising results, showing cannabis flowers with high tetrahydrocannabinol (THC) levels may be a helpful remedy for reducing symptoms of depression.

Treatment

Cannabis Law Report

NOVEMBER 10, 2021

Rare Cannabinoid Company has launched a new website designed to help hemp and cannabis consumers learn how specific rare cannabinoids and terpenes may improve their mental and physical health. ” For those seeking even more specialized care, they can find a cannabinoid health advisor near them.

Terpenes

The Cannigma

FEBRUARY 3, 2022

For example, CBD (a non-intoxicating cannabinoid) has been shown to carry unique benefits for athletes by boosting performance and optimizing recovery. Jordan Tishler MD, President of the Association of Cannabinoid Specialists and CEO at inhaleMD. These effects can all lend themselves to an enhanced yoga practice.

Digestion

Veriheal

AUGUST 7, 2022

As of 2020, the market was worth CAD $2.6 However, CUD and the withdrawal symptoms that stem from it—paranoia, sleep problems, mood swings, etc.—are One particular study featured in the 2019 edition of the American Journal of Psychiatry found that the cannabinoid CBD may ease drug cravings and feelings of anxiety in heroin addicts.

Consumption

Miss Marijuana

MARCH 17, 2020

They also come with descriptors such as Full-Spectrum (includes a variety of cannabinoids, such as CBD, THC, and CBN) or Isolate (CBD only). The capsules’ testimonials show that users report a sense of being at ease, better sleep, and relaxed muscles. A post shared by Lazarus Naturals (@lazarusnaturalscbd) on Mar 4, 2020 at 3:00pm PST.

Oil

Cannabis Law Report

DECEMBER 15, 2021

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

Pharmaceutical

Cannabis Law Report

JUNE 7, 2021

IGC received approval to proceed with the trial from the FDA on July 30, 2020. To IGC’s knowledge, this is the first human clinical trial using low doses of natural THC, a psychoactive member of the cannabinoid class of natural products produced by the Cannabis sativa plant, on Alzheimer’s patients. www.igcinc.us www.igcpharma.com.

Clinical Trials

Veriheal

OCTOBER 9, 2020

Mental health can suffer under the pandemic, according to the CDC, due to : (1) fear and worry over one’s own health and the health of loved ones, (2) changes in everyday activities such as eating, sleeping, and social activities as well as (3) increased use of substances such as tobacco and alcohol.

Consumption

Cannabis Law Report

OCTOBER 7, 2021

UM is considered one of the leading cannabinoid research institutes in the United States. The research partnership aims to identify novel cannabinoids to be patented for therapeutic use in accordance with the U.S. The project’s major emphasis is to explore the chemistry and biology of minor cannabinoids beyond cannabidiol (CBD).

Cannabinoids

Veriheal

APRIL 12, 2023

What Science Says About CBD and Chronic Pain-Related Spinal Cord Injuries The University of Sydney , in collaboration with the Lambert Initiative for Cannabinoid Therapeutics, has launched a pioneering medical trial to investigate the efficacy of CBD in treating chronic pain resulting from spinal cord injuries.

Chronic Pain

Cannabis Law Report

JULY 16, 2019

On July 29 in the US, Hemple will launch Fleur Marche – a cannabinoid skincare range. MMJ Group Holdings Ltd ( ASX:MMJ ) (OTCMKTS:MMJJF) is watching closely as its investee Hemple has launched its hemp and cannabinoid (CBD) brand in the US. Ultimately this means better value for money for the customer.”.

Cannabinoids

The Cannigma

AUGUST 29, 2021

to 4.2%, according to a study published in February, 2020. Even the American Association of Retired Persons (AARP) now supports the use of medical marijuana in states where it is legal and officially calls for more research on the medicinal use of cannabinoids. ? Get your medical card now with The Cannigma Medical.

Blood Pressure

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). 1 Simultaneously, the AAFP acknowledges preliminary evidence indicates marijuana and cannabinoids may have potential therapeutic benefits, while also recognizing subsequent negative public health and health outcomes associated with cannabis use.

Cannabinoids

Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. of prescriptions were for sleep disorders. The data also shows that prior to 2020, people between 45 and 52 years old had the highest incidence of prescriptions. The Guardian writes.

Medicine

Cannabis Law Report

MARCH 16, 2020

In Dec 2019, Jack Woodhouse illuminated Why CBG Flowers Could Become the Trendiest Bud of 2020 ? Available in nearly all 50 states, its popularity has revealed a huge demand by the public for non-psychoactive cannabinoids and relief. . CBG BACKGROUND—. Thanks to the 2018 Farm Bill , CBD-rich hemp flower has gone mainstream.

Cannabinoids

CannaMD

DECEMBER 9, 2020

In August of 2020, the American Heart Association (AHA) released a position paper titled “Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association.” These can include anxiety, irritability, depression, sleep disorders, and headaches.

Marijuana

TheAnswerPage

MAY 24, 2021

As of January 2020, how many Americans were using marijuana-based products for medicinal purposes? Some of the many ailments being treated with marijuana include: chronic pain, PTSD, depression, sleep disorders, multiple sclerosis (MS), cancer-related ailments, and GI disorders. 2020 Apr 15;411:116717. Epub 2020 Jan 30.

Chronic Pain

The Cannigma

MARCH 26, 2021

Later in the show, Matthew discusses the potential for cannabinoids to experience a huge upswing as the industry matures. The key question he asks is whether “THC is popular because it’s the best cannabinoid? If I purchase an indica and I consumed it 40 minutes before going to bed, with the intent of getting better night’s sleep.

Education

Cannabis Law Report

JUNE 3, 2021

Study To Explore Effects of cbdMD’s Proprietary Cannabinoid Blend On Pets Who Suffer From Osteoarthritis. Our cbdMD brand currently includes over 130 SKUs of high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts, CBD sleep aids and CBD drink mixes. cbdMD, Inc.

Programs

Kind Meds (Cannabis Education Blog)

SEPTEMBER 13, 2022

CBD and THC are the two foremost cannabinoid compounds available in products from smokeable flower to edibles, topicals, and more. However, CBD is another critical cannabinoid that doesn’t get you high. Usually, people will benefit from experimenting for a while to determine which cannabinoid is best for them. Is cannabis safe?

THC

Cannabis Law Report

MAY 10, 2022

The study, led by the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics , found anxiety was among the top three reasons for a medicinal cannabis prescription. Very few studies have also been done examining cannabis for the treatment of sleep disorders. Sydney-based writer Rocky, 31, embodies this process.

Medicine

Cannabis Law Report

JUNE 1, 2021

vs. Q4 2020. vs. Fiscal 2020. Revenues : Net revenue of $148 million in Q4 2021 was an increase of 38% versus Q4 2020. Total net cannabis revenue of $101 million in Q4 2021 and $379 million in FY 2021, represented an increase of 27% and 28% over Q4 2020 and the prior year, respectively. 2,800) bps. Net revenue.

Data

Veriheal

NOVEMBER 8, 2022

It should be noted that some strains suppress appetite due to a high content of the cannabinoid THCV. . from 2000-2020. . digestive problems such as heartburn or gallbladder disease, sleep apnea, osteoarthritis and are even at the risk of presenting with more severe covid-19 symptoms. .

Research and Development